|The Advisory Committee|
Sara Hitchman, Co-Chair
Sara Hitchman completed her MASc in Applied Psychology, and her PhD in Psychology at the University of Waterloo, Canada. Her current research interests include global tobacco control policy, electronic cigarettes, norms towards tobacco and nicotine use, standardised packaging, and cigarette health warnings. Prior to coming to King’s, Sara worked with the International Tobacco Control Project, spent time at the University of California San Francisco as a post-doctoral fellow, and worked with the World Heart Federation and the World Health Organization. Sara is a member of the UK Centre for Tobacco and Alcohol Studies.
Andrea Villanti, Co-Chair
Andrea Villanti, Ph.D., M.P.H., is director for Regulatory Science and Policy at the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative. She also holds an adjunct faculty appointment at the Johns Hopkins Bloomberg School of Public Health.
Dr. Villanti’s primary focus is on translational research to improve tobacco control policy and program decision-making. Her area of expertise is in young adult tobacco use. She is the Principal Investigator on Truth Initiative’s Young Adult Cohort Study and has a two-year study, funded by the National Cancer Institute to examine social smoking in young adults. She is also a collaborating research scientist on a five-year study, funded by the National Institute on Drug Abuse and the Food and Drug Administration, to examine the impact of FDA regulations on tobacco products.
Jonathan Foulds, PhD. is a Professor of Public Health Sciences and Psychiatry at Penn State University, College of Medicine. After obtaining a first class honors degree in psychology at University of Aberdeen in Scotland, he trained as a clinical psychologist at the University of Glasgow, and then spent most of his career developing and evaluating methods to help smokers beat their addiction to tobacco. He obtained his PhD at the Institute of Psychiatry, University of London and worked at St George’s Hospital Medical School as the UK’s first “lecturer in tobacco addiction”. He then moved to University of Surrey and continued to work as a principal clinical psychologist at Broadmoor Hospital, a large maximum security facility for mentally disordered offenders. He was on the Management Group of the Hungarian Anti-Smoking Campaign (1995-6), has been a technical leader of a World Health Organization project to improve the regulation of tobacco dependence treatment in Europe (2000), and was Director of Research for the UK charity, Quit, which ran the largest telephone helpline for smokers in the world at that time. From 2000-2010 he was the director of the Tobacco Dependence Program at the University of Medicine & Dentistry of New Jersey (now Rutgers)– School of Public Health. Although primarily funded for service and training activities, TDP program members published over 90 articles on tobacco during that period. He was a founding member and Vice President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD) 2004-6. In the USA he has been a principal investigator on grants totaling well over $27 million, and has been invited to speak on smoking cessation in over 15 countries. Dr. Foulds acts as a Health Expert on the www.WebMD.com Smoking Cessation Community. He has published over 100 papers on tobacco in peer-reviewed scientific journals and continues to treat addicted smokers, teach on smoking cessation and conduct research on tobacco and health at Penn State College of Medicine in Hershey, PA.
David Hammond is an Associate Professor in the School of Public Health & Health Systems at the University of Waterloo. His research focuses upon tobacco control policy in the areas of health communications, packaging, and product regulation, as well as nutritional labeling and obesity prevention. Professor Hammond works closely with regulators around the world and has served as an Advisor for the World Health Organization. He recently received the Canada’s Premier Young Researcher Award from the Canadian Institutes of Health Research and is a past recipient of the Canadian Medical Association Journal’s Top Canadian Achievements in Health Research Awards 2009 for his work with Geoff Fong and Mary Thompson as part of the International Tobacco Control Policy project, conducted in more than a dozen low and middle income countries.
Desmond Jenson is a staff attorney with the Public Health Law Center. He works primarily on shaping federal tobacco control policy by encouraging the Food and Drug Administration to enact strong tobacco control regulations based on its authority under the Family Smoking Prevention and Tobacco Control Act. Desmond also educates the public health and scientific communities about the rulemaking process and highlights opportunities to engage the FDA to create better regulation. He helps the public health community in its efforts to close regulatory gaps and enact novel regulations that anticipate future regulatory issues. Desmond provides legal technical assistance to members of the public health community who wish to participate in the regulatory process and he also provides litigation support to defend tobacco control policies that are challenged by the tobacco industry.
Paula Keller, M.P.H. is Director of Cessation Programs at ClearWay MinnesotaSM, an independent, non-profit organization that improves the health of Minnesotans by reducing the harm caused by tobacco through research, action and collaboration. Ms. Keller administers QUITPLAN® Services (Minnesota’s free population-based cessation services), oversees ClearWay Minnesota’s cessation policy work, and manages cessation evaluation activities. Prior to joining ClearWay Minnesota in 2010, she was Senior Policy Advisor at the Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health. She has 14 years of tobacco control experience including work with quitlines, health systems change, cessation policy and increasing utilization of evidence-based treatment. She has also worked on public health initiatives for the federal government and other non-profit organizations. She is a member of the North American Quitline Consortium’s Advisory Council. Ms. Keller earned her bachelor’s degree in community health education from the University of Wisconsin-La Crosse and her MPH in public health policy and administration from the University of Michigan.
Robert Schwartz is Executive Director of the Ontario Tobacco Research Unit and Associate Professor in the Dalla Lana School of Public Health at the University of Toronto and Senior Scientist, Centre for Addiction and Mental Health. Dr. Schwartz is Editor-in-Chief of Canadian Journal of Program Evaluation and Principal Investigator of the CIHR Strategic Training Program in Public Health Policy. At OTRU, Dr. Schwartz directs research, evaluation, knowledge exchange and capacity building programs. OTRU engages in research, comprehensive evaluation and monitoring surveillance, performance measurement and evaluation support and quality assurance. His research interests include (1) Tobacco Control Policy, (2) Evaluation of Complex Strategy Initiatives, (3) Evaluation of Tobacco Control Programs and Policies, (4) Public Health Policy (5) Accountability (6) The Politics and Quality of Evaluation, (7) Performance Measurement and Performance Auditing, He has published widely about tobacco control, accountability, public health policy, policy change, program evaluation and government – third sector relations.